THYROID CANCER
Clinical trials for THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER trials appear
Sign up with your email to follow new studies for THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug enters first human tests
Disease control Not yet recruitingThis is a very early study to find the safest dose of a new drug called 177Lu-INN805 for people with advanced solid tumors that haven't responded to standard treatments. It will enroll about 10 patients with cancers like head & neck, lung, breast, or sarcoma to test how the body …
Matched conditions: THYROID CANCER
Phase: EARLY_PHASE1 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Faster relief for thyroid cancer patients? study tests new medication combo
Disease control Not yet recruitingThis study aims to find the best way to restart thyroid hormone medication after treatment for high-risk thyroid cancer. Researchers will compare two approaches: a standard single hormone versus a combination of two hormones. They want to see which helps patients feel better fast…
Matched conditions: THYROID CANCER
Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Targeted radiation tested for tough thyroid cancer
Disease control Not yet recruitingThis study is testing a new radioactive drug designed to target and treat a rare, aggressive form of thyroid cancer called Hurthle cell cancer. It is for adults whose cancer has spread and no longer responds to standard radioactive iodine treatment. The main goals are to find a s…
Matched conditions: THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug duo tested to fight advanced thyroid cancer
Disease control Not yet recruitingThis study is testing whether combining two drugs, anlotinib and benmelstobart, can help control advanced thyroid cancer that has continued to grow after initial treatment. It is for adults whose cancer cannot be surgically removed or has spread. The main goal is to see how many …
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New program aims to guide young cancer survivors through critical Follow-Up care
Disease control Not yet recruitingThis study is creating and testing a patient navigation program to help young adults who have survived cancer. The program aims to guide survivors to get the recommended primary care and cancer check-ups they need. Researchers will first adapt an existing program for young surviv…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Less thyroid surgery, same cancer control? major trial aims to find out
Disease control Not yet recruitingThis study aims to determine if a smaller, more conservative surgery is as effective as complete thyroid removal for treating certain low-risk thyroid cancers located in the middle of the gland. It will involve 520 adults with small, unspread tumors and directly compare cancer re…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Short video aims to ease worries and improve recovery for thyroid patients
Symptom relief Not yet recruitingThis study tests whether a brief educational video helps people cope better with radioiodine treatment for thyroid conditions like cancer or hyperthyroidism. Researchers will compare two groups of 80 patients—one watching a standard health video and another watching a video speci…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: University of Auckland, New Zealand • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New therapy aims to ease mental burden for advanced cancer patients
Symptom relief Not yet recruitingThis study is testing whether a specialized form of talk therapy, called Meaning-Centered Psychotherapy for Latinos (MCP-L), can better reduce anxiety and depression and improve quality of life for Mexican patients with advanced breast, prostate, colorectal, or thyroid cancer. It…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC